Atlizumab is a humanized monoclonal antibody which is used as an immunosuppressive drug.
Read article at Wikipedia
Atlizumab
Facts from the Community
From the BioVenturist base
Stage of development:
Target/Biomolecule of Interest:
We can tell you that Atlizumab is a
If you know more about Atlizumab, you can add more facts here »
Similar topics in Freebase
-
Ranibizumab
Ranibizumab (trade name Lucentis) is a monoclonal antibody fragment derived from the same parent murine antibody as bevacizumab (Avastin). It is much smaller than the parent molecule and has been affinity matured to provide stronger binding to VEGF-A. It is an anti-angiogenic that has been approved... -
Lintuzumab
Lintuzumab is a humanized monoclonal antibody used in the treatment of cancer. -
SGN-70
-
SGN-40
-
Palivizumab
Palivizumab (brand name Synagis or Abbosynagis) is a monoclonal antibody produced by recombinant DNA technology. It is used in the prevention of Respiratory Syncytial Virus (RSV) infections. It is recommended for certain infants that are high-risk (because of prematurity or other medical problems),... -
Nimotuzumab
A humanized monoclonal antibody directed against the epidermal growth factor receptor (EGFR) with potential antineoplastic activity. Nimotuzumab binds to and inhibits EGFR, resulting in growth inhibition of tumor cells that overexpress EGFR. This agent may act synergistically with radiation therapy.... -
SGN-75
-
Apolizumab
Apolizumab is a humanized monoclonal antibody that is being studied as a treatment for hematologic cancers. -
Gemtuzumab ozogamicin
Gemtuzumab ozogamicin (marketed by Wyeth as Mylotarg) is a monoclonal antibody used to treat acute myelogenous leukemia. It is a monoclonal antibody to CD33 linked to a cytotoxic agent from the class of calicheamicins. CD33 is expressed in most leukemic blast cells but also in normal hematopoietic... -
Panitumumab
Panitumumab (INN), formerly ABX-EGF, is a fully human monoclonal antibody specific to the epidermal growth factor receptor (also known as EGF receptor, EGFR, ErbB-1 and HER1 in humans). Panitumumab is manufactured by Amgen and marketed as Vectibix. It was approved by the U.S. Food and Drug...
You can help improve this topic by adding more facts here